Corient Capital Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $429K | Hold |
1,418
| – | – | 0.03% | 372 |
|
|
2022
Q2 | $429K | Buy |
1,418
+151
| +12% | +$45.7K | 0.03% | 383 |
|
|
2022
Q1 | $520K | Buy |
1,267
+35
| +3% | +$14.4K | 0.03% | 382 |
|
|
2021
Q4 | $578K | Buy |
1,232
+48
| +4% | +$22.5K | 0.04% | 341 |
|
|
2021
Q3 | $503K | Buy |
1,184
+46
| +4% | +$19.5K | 0.04% | 356 |
|
|
2021
Q2 | $409K | Buy |
1,138
+130
| +13% | +$46.7K | 0.03% | 414 |
|
|
2021
Q1 | $284K | Buy |
1,008
+149
| +17% | +$42K | 0.02% | 461 |
|
|
2020
Q4 | $243K | Buy |
859
+117
| +16% | +$33.1K | 0.02% | 432 |
|
|
2020
Q3 | $204K | Buy |
+742
| New | +$204K | 0.02% | 448 |
|